| abstract |
Formula (I) (Wherein R 1 represents lower alkyl optionally having substituents, etc., and R 2 and R 3 are the same or different and represent lower alkyl optionally having substituents, etc .; R 4 and R 5 are the same or different and represent a hydrogen atom or the like, Q 1 -Q 2 -Q 3 represents CH═CH—CH═CH or the like, Y represents a single bond, or the like, Z 1 -Z 2 represents C = CR 13 (wherein R 13 represents a hydrogen atom or the like, and A represents -COOH or the like) or a pharmaceutically acceptable salt thereof. A PPARγ agonist containing a salt as an active ingredient is provided. |